Protein C: a potential biomarker in severe sepsis and a possible tool for monitoring treatment with drotrecogin alfa (activated)

INTRODUCTION: Drotrecogin alfa (activated; DrotAA) treatment, a 96-hour infusion, reduces 28-day mortality in severe sepsis to approximately 25%. The question remains whether a longer infusion or higher dose could increase rate of survival. The goal of this study was to identify a dependable, sensit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Shorr, Andrew F, Nelson, David R, Wyncoll, Duncan LA, Reinhart, Konrad, Brunkhorst, Frank, Vail, George Matthew, Janes, Jonathan
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2008
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2447591/
https://ncbi.nlm.nih.gov/pubmed/18394162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc6854
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados